Cited by 58Mangiferin and Mango ExtractsNanoparticle-Based Drug DeliveryPhytochemicals and Antioxidant Activities

Anti-oxidative effect of mangiferin-chitosan nanoparticles on oxidative stress-induced renal cells

Samadarsi, Rohini, Dutta, Debjani·2020·International Journal of Biological Macromolecules

Abstract

Oxidative stress is considered to be the leading cause of many chronic and degenerative diseases leading to death and disability. Antioxidant therapy could be efficient in preventing oxidative stress-induced damages in cells. In the present study the efficacy of mangiferin-chitosan nanoparticles (MCNs) as a therapeutic agent against the oxidative stress, since mangiferin (MGF), a polyphenol protects and attenuates oxidative stress against various diseases. However, the bioactivity of MGF does not result in vivo biological effect owing to its low bioavailability and poor solubility. Mangiferin nanoparticles (NPs) were developed to improve the solubility and bioavailability of mangiferin. Nanoparticles had significant free radical scavenging activity in the cell-free system and had a synergistic action with phase II antioxidant enzymes such as catalases and peroxidases. A nephropathic system was developed to investigate the attenuative role of mangiferin-chitosan nanoparticles against induced oxidative stress, on normal kidney epithelial (NKE) cells. Pre-treatment with the nanoparticles exclusively prevented the induction of cytotoxicity induced by NaF and maintained the level of intracellular antioxidant enzyme in the cells. Nanoparticles had significant lipid peroxidation and protein oxidation inhibition activities. These nanoparticles can be used in food and pharmaceutical industries as a therapeutic agent to prevent the oxidative stress-induced health disorders.

Integrity signals

Registry

Crossref · 10.1016/j.ijbiomac.2020.02.112

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Multiple delivery approaches (nanostructured lipid carriers, polymeric and chitosan-based nanogels, phospholipid complexes, targeted nanoparticles) have improved MGF exposure in preclinical systems.

    “Multiple approaches have improved exposure in preclinical systems, including nanostructured lipid carriers, polymeric and chitosan-based nanogels, phospholipid complexes (2,172,173), and targeted nanoparticles designed to enhance intestinal uptake or lymphatic transport and to stabilize MGF against rapid metabolism (172,174-176).”

Cites

Flagged first, then by citations

1 of the 29 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Samadarsi, R., & Dutta, D.
Affiliations
National Institute of Technology Durgapur (IN)
Corresponding author
Dutta, Debjani
Venue
International Journal of Biological Macromolecules
Publisher
Elsevier BV
Published
2020-05
Volume
151
Pages
36-46
ISSN
0141-8130 (ISSN-L)
OpenAlex
W3006639456
Cited by
57
References
29
Citations by year
2026: 9 · 2025: 14 · 2024: 11 · 2023: 6 · 2022: 8 · 2021: 8 · 2020: 1
FWCI
6.37
Type
journal article
Language
en
Open access
closed
Locations
  • International Journal of Biological Macromolecules (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Complementary and alternative medicine › Mangiferin and Mango Extracts
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
  • Health Sciences › Medicine › Biochemistry › Phytochemicals and Antioxidant Activities
Keywords
mangiferin, chitosan nanoparticles, oxidative stress, antioxidant activity, renal epithelial cells, lipid peroxidation, protein oxidation, catalase, peroxidase, phase II antioxidant enzymes, bioavailability enhancement, kidney disease
MeSH terms
Antioxidants, Cell Survival, Cells, Cultured, Kidney, Models, Biological, Oxidation-Reduction, Spectrum Analysis, Reactive Oxygen Species, Oxidative Stress, Intracellular Space, Xanthones, Chitosan, Nanoparticles

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review